Structural Basis for Inhibition of the Cardiac Sodium Channel by the Atypical Antiarrhythmic Drug Ranolazine
Lenaeus, M.J., Tonggu, L.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Sodium channel protein type 5 subunit alpha,Green fluorescent protein | 1,838 | Rattus norvegicus, Aequorea victoria | Mutation(s): 0  Gene Names: Scn5a, GFP Membrane Entity: Yes  | ||
UniProt | |||||
Find proteins for P42212 (Aequorea victoria) Explore P42212  Go to UniProtKB:  P42212 | |||||
Find proteins for P15389 (Rattus norvegicus) Explore P15389  Go to UniProtKB:  P15389 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Groups | P42212P15389 | ||||
Glycosylation | |||||
Glycosylation Sites: 3 | Go to GlyGen: P15389-1 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 5 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
6OU Query on 6OU | O [auth A] P [auth A] Q [auth A] R [auth A] S [auth A] | [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate C39 H76 N O8 P FHQVHHIBKUMWTI-OTMQOFQLSA-N | |||
Y01 Query on Y01 | AA [auth A] BA [auth A] CA [auth A] DA [auth A] EA [auth A] | CHOLESTEROL HEMISUCCINATE C31 H50 O4 WLNARFZDISHUGS-MIXBDBMTSA-N | |||
XHO (Subject of Investigation/LOI) Query on XHO | N [auth A] | (R)-ranolazine C24 H33 N3 O4 XKLMZUWKNUAPSZ-HXUWFJFHSA-N | |||
NAG Query on NAG | D [auth A] E [auth A] F [auth A] H [auth A] K [auth A] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
BMA Query on BMA | G [auth A], I [auth A], J [auth A] | beta-D-mannopyranose C6 H12 O6 WQZGKKKJIJFFOK-RWOPYEJCSA-N |
Task | Software Package | Version |
---|---|---|
MODEL REFINEMENT | PHENIX |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) | United States | K08 HL145630-05 |